Intracameral treatment significantly reduces postoperative CME compared with topical steroids
Intracameral phenylephrine/ketorolac and topical NSAIDS significantly reduced postoperative cystoid macular edema (CME), breakthrough iritis, and pain after cataract surgery compared with topical steroids and NSAIDS, according to a presentation at the 2020 ASCRS Virtual Meeting.
In this retrospective 2-cohort study, 2218 eyes of 1402 patients undergoing cataract surgery received either intracameral phenylephrine 1.0%/ketorolac 0.3% during or topical loteprednol 0.5% 2 days postoperatively, tapered over the course of 4 weeks.
Researchers found that the incidence of CME was approximately 3 times lower in the study group. Significantly lower incidence rates of iritis and pain were found in the study group.
“These findings suggest that phenylephrine/ketorolac may be a better prophylactic regimen for postoperative CME, breakthrough iritis, and pain than regimens involving compliance-dependent topical steroids and topical NSAIDs,” concluded the presenter.
Visco DM, et al. Effect of intracameral phenylephrine 1.0%/ketorolac 0.3% on cystoid macular edema, breakthrough iritis, and pain following cataract surgery. Presented at: 2020 ASCRS Virtual Meeting